デグー(とみー)@日本

[デグー(とみー)@日本 @PharmaAI]

両親が週末遊びに来てくれることになってるんだけど、娘はいつも帰省のときに持っていけないオモチャを見せるのを楽しみにしてるし、母は娘が喜びそうなものをと色々準備してくれてる☺️
どうか雨も降らないで楽しく過ごせますように☀️👧👱🧔♂️💖

[デグー(とみー)@日本 @PharmaAI]

ゲームは当時に姉がやっていたのを横で見て、後���実況でも見ました
吹雪士郎と綱海条介が好きです✌

[デグー(とみー)@日本 @PharmaAI]

いいねこのコラボ
ゴマキの存在感が凄い。

[デグー(とみー)@日本 @PharmaAI]

お買い物マラソンを逃したこのタイミングで娘用のスパッツをポチりました…
他にも地味に欲しいタオルホルダーとか風呂のコーナーにマグネットで付ける棚とかいくつかあるんですけどそれは次回のマラソンでいいか…

[デグー(とみー)@日本 @PharmaAI]

モンハンのスクショが携帯にとんでない！なぜだ🤔
あっお疲れ様でした！

[デグー(とみー)@日本 @PharmaAI]

無政府主義者「アナキズム」とは
国家や政府などの、あらゆる権力、支配構造の否定
個人の自立と自由に基づく、平等で相互扶助的な
社会の実現を目指す人々
たんなる困難、無秩序ではなく「権威なき社会」
を理想とする政治思想
「支配の否定」、「国家の法律・軍隊・警察・宗教」

[デグー(とみー)@日本 @PharmaAI]

First Application of AlphaFold in Identifying Potential Liver Cancer Drug https://t.co/alo2c20jZY via @GENbio

[Insilico Medicine @InSilicoMeds]

Thank you! Very honored to receive the Company of the Year award from @BioCentury-BayHelix East-West Summit! @biogerontology

[Insilico Medicine @InSilicoMeds]

Thank you @HKBusinessMag for recognizing Insilico Medicine with a Technology Excellence Award! #HongKong #biotech #ai #drugdiscovery @biogerontology

[デグー(とみー)@日本 @PharmaAI]

Biotech's top 10 money raisers of 2021 https://t.co/epDGLYdkfO

[Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) @biogerontology]

This session at the @AACR will be exciting. For years I enjoyed the detailed analysis of the progress in CADD/AIDD In The Pipeline. Excited to be part of this debate with the giants.
@Dereklowe @ClaraDChrist @HartungIngo Mary Mader, Joachim Rudolph
#AACR2022

[デグー(とみー)@日本 @PharmaAI]

@InSilicoMeds 's first AI-discovered antifibrotic drug goes first-in-... https://t.co/B0fOMkaUCC #AI #drugdiscovery #AAIH #IPF

[デグー(とみー)@日本 @PharmaAI]

Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer https://t.co/i21QsFHOqn

[デグー(とみー)@日本 @PharmaAI]

@InSilicoMeds Appoints the Former Chief Medical Officer of Schering Plough, Dr. Robert Spiegel, MD, FACP, as acting Chief Medical Officer (CMO) to Oversee the Clinical Translation of its Preclinical Pipeline Assets https://t.co/O5ePtFpSCs

[デグー(とみー)@日本 @PharmaAI]

@InSilicoMeds taps 4B Technologies’ neurological know-how to build AI-designed ALS drugs https://t.co/2Z5OTUzlmJ

[GSK @GSK]

We're sad to hear of the death of Tachi Yamada, who was a huge part of our history, pictured here during his time as our chairman of R&D. He had an immense impact on GSK and global health. Our thoughts are with his family, friends and colleagues.

[デグー(とみー)@日本 @PharmaAI]

Insilico Medicine’s AI engines continue to churn out new drug candidates, now in kidney fibrosis https://t.co/ByRFv4pRWa

[デグー(とみー)@日本 @PharmaAI]

Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis Discovered Using End-to-End Artificial Intelligence Engine https://t.co/b2NgASSGru via @InSilicoMeds

[デグー(とみー)@日本 @PharmaAI]

@InSilicoMeds and Westlake Pharma Announce Cooperation Relationship on Accelerating the Innovative Drugs R&D for Novel Coronavirus https://t.co/m2SSZGftp7 via @Yahoo

[Insilico Medicine @InSilicoMeds]

Insilico Medicine is excited to collaborate with Teva! https://t.co/4yOco9vyMh